Cardioneuroablation for Reflex Syncope: Efficacy and Effects on Autonomic Cardiac Regulation-A Prospective Randomized Trial
- PMID: 36114133
- DOI: 10.1016/j.jacep.2022.08.011
Cardioneuroablation for Reflex Syncope: Efficacy and Effects on Autonomic Cardiac Regulation-A Prospective Randomized Trial
Abstract
Background: Treatment of cardioinhibitory vasovagal syncope (VVS) is difficult. Recently, cardioneuroablation (CNA) has emerged as a new therapeutic option.
Objectives: This study sought to assess the effects of CNA on syncope recurrences in patients with VVS.
Methods: This study was a prospective, open, randomized, controlled, investigator-initiated trial comparing CNA versus optimal nonpharmacologic therapy in patients with cardioinhibitory VVS. Patients were included if they had documented symptomatic cardioinhibitory or mixed VVS and positive atropine test. CNA was performed using radiofrequency ablation of the ganglionated plexi from the left and right atria. Follow-up lasted 2 years. Primary endpoint was time to first syncope recurrence. Secondary endpoints included changes in sinus rhythm and heart rate variability measured in Holter electrocardiography at baseline and 3, 12, and 24 months after CNA, as well as changes in quality of life at baseline and after completion of follow-up.
Results: A total of 48 patients (17 male, mean age 38 ± 10 years, 24 in CNA group, 24 in control group) entered the study. The primary endpoint occurred in 2 patients (8%) from the CNA group versus 13 control patients (54%) (P = 0.0004). After CNA the mean sinus rhythm at 24-hour Holter electrocardiography was significantly faster and heart rate variability parameters significantly changed toward parasympathetic withdrawal compared with baseline values. Quality of life significantly improved in the CNA group (30 ± 10 points vs 10 ± 7 points; P = 0.0001), whereas it remained stable in control patients (31 ± 10 points vs 30 ± 10 points; P = 0.5501).
Conclusions: This is the first randomized study documenting efficacy of CNA in patients with cardioinhibitory VVS. Larger studies are needed to confirm these findings. (Cardioneuroablation for Reflex Syncope [ROMAN]; NCT03903744).
Keywords: ablation; cardioneuroablation; ganglionated plexi; syncope; vasovagal syncope.
Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Similar articles
-
Clinical impact of aging on outcomes of cardioneuroablation for reflex syncope or functional bradycardia: Results from the cardionEuroabLation: patiEnt selection, imaGe integrAtioN and outComEs-The ELEGANCE multicenter study.Heart Rhythm. 2023 Sep;20(9):1279-1286. doi: 10.1016/j.hrthm.2023.06.007. Epub 2023 Jun 15. Heart Rhythm. 2023. PMID: 37329936
-
Cardioneuroablation changes the type of vasovagal response in patients with asystolic reflex syncope.Auton Neurosci. 2021 Nov;235:102838. doi: 10.1016/j.autneu.2021.102838. Epub 2021 Jun 24. Auton Neurosci. 2021. PMID: 34186273
-
Clinician needs and perceptions about cardioneuroablation for recurrent vasovagal syncope: An international clinician survey.Heart Rhythm. 2021 Dec;18(12):2160-2166. doi: 10.1016/j.hrthm.2021.08.018. Epub 2021 Aug 19. Heart Rhythm. 2021. PMID: 34419666
-
Potential consequences of cardioneuroablation for vasovagal syncope: A call for appropriately designed, sham-controlled clinical trials.Heart Rhythm. 2024 Apr;21(4):464-470. doi: 10.1016/j.hrthm.2023.12.004. Epub 2023 Dec 16. Heart Rhythm. 2024. PMID: 38104955 Review.
-
Cardioneuroablation in patients with vasovagal syncope: An updated systematic review and meta-analysis.Heart Rhythm. 2024 Jul 25:S1547-5271(24)03079-0. doi: 10.1016/j.hrthm.2024.07.103. Online ahead of print. Heart Rhythm. 2024. PMID: 39067734 Review.
Cited by
-
Effect of age on clinical impact and mid-term denervation in patients undergoing cardioneuroablation.Sci Rep. 2024 Nov 11;14(1):27546. doi: 10.1038/s41598-024-78665-z. Sci Rep. 2024. PMID: 39528539 Free PMC article.
-
Editorial: Autonomic involvement in arrhythmias: translating mechanisms to therapy.Front Cardiovasc Med. 2024 Oct 25;11:1504473. doi: 10.3389/fcvm.2024.1504473. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39526182 Free PMC article. No abstract available.
-
TELE-SPACER - a randomized clinical trial protocol: Cardioneuroablation versus pacemaker implantation in the treatment of vagally-mediated atrio-ventricular block.Cardiol J. 2024;31(5):766-773. doi: 10.5603/cj.102195. Epub 2024 Oct 18. Cardiol J. 2024. PMID: 39422462 Free PMC article. No abstract available.
-
[Diagnostics and treatment of syncope].Herz. 2024 Oct;49(5):394-403. doi: 10.1007/s00059-024-05260-3. Epub 2024 Aug 27. Herz. 2024. PMID: 39190136 German.
-
Cardioneuroablation: the known and the unknown.Front Cardiovasc Med. 2024 Jul 26;11:1412195. doi: 10.3389/fcvm.2024.1412195. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39131701 Free PMC article. Review.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
